Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Mummery, Christine L  [Clear All Filters]
2024
Novoa JJ, Westra IM, Steeneveld E, Neves NFonseca, Arendzen CH, Rajaei B, Grundeken E, Yildiz M, van der Valk W, Salvador A, et al. Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products. Cytotherapy. 2024.
2023
Tsui H, van Kampen SJohannes, Han SJi, Meraviglia V, van Ham WB, Casini S, van der Kraak P, Vink A, Yin X, Mayr M, et al. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy. Sci Transl Med. 2023;15(688):eadd4248.
Nahon DM, Ganesh S, van den Hil FE, Freund C, Mummery CL, Orlova VV. Genetic repair of a human induced pluripotent cell line from patient with Dutch-type cerebral amyloid angiopathy. Stem Cell Res. 2023;71:103180.
Shoji J-Y, Davis RP, Mummery CL, Krauss S. Global Meta-Analysis of Organoid And Organ-on-Chip Research. Adv Healthc Mater. 2023:e2301067.
Ludwig TE, Andrews PW, Barbaric I, Benvenisty N, Bhattacharyya A, Crook JM, Daheron LM, Draper JS, Healy LE, Huch M, et al. ISSCR standards for the use of human stem cells in basic research. Stem Cell Reports. 2023;18(9):1744-1752.
Jordan R, Ford-Scheimer SL, Alarcon RM, Atala A, Borenstein JT, Brimacombe KR, Cherry S, Clevers H, Davis MI, Funnell SGP, et al. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. J Infect Dis. 2023.
2022
Ramovs V, Janssen H, Fuentes I, Pitaval A, Rachidi W, Lopes SMChuva de, Freund C, Gidrol X, Mummery CL, Raymond K. Characterization of the epidermal-dermal junction in hiPSC-derived skin organoids. Stem Cell Reports. 2022.
Blanch-Asensio A, van der Vaart B, Vinagre M, Groen E, Arendzen C, Freund C, Geijsen N, Mummery CL, Davis RP. Generation of AAVS1 and CLYBL STRAIGHT-IN v2 acceptor human iPSC lines for integrating DNA payloads. Stem Cell Res. 2022;66:102991.
Stein JM, Arslan U, Franken M, de Greef JC, Harding SE, Mohammadi N, Orlova VV, Bellin M, Mummery CL, van Meer BJ. Software Tool for Automatic Quantification of Sarcomere Length and Organization in Fixed and Live 2D and 3D Muscle Cell Cultures In Vitro. Curr Protoc. 2022;2(7):e462.
Orlova VV, Nahon DM, Cochrane A, Cao X, Freund C, van den Hil F, Westermann CJJ, Snijder RJ, van Amstel JKristian P, Dijke PTen, et al. Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip. Stem Cell Reports. 2022.
2021
Campostrini G, Windt LM, van Meer BJ, Bellin M, Mummery CL. Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration. Circ Res. 2021;128(6):775-801.
2020
van den Brink L, Brandão KO, Yiangou L, Mol MPH, Grandela C, Mummery CL, Verkerk AO, Davis RP. Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties. Stem Cell Res. 2020;43:101698.
Stein JM, Mummery CL, Bellin M. Engineered models of the human heart: directions and challenges. Stem Cell Reports. 2020.
Iendaltseva O, Orlova VV, Mummery CL, Danen EHJ, Schmidt T. Fibronectin Patches as Anchoring Points for Force Sensing and Transmission in Human Induced Pluripotent Stem Cell-Derived Pericytes. Stem Cell Reports. 2020.
Bouma MJ, Orlova V, van den Hil FE, Mager H-J, Baas F, de Knijff P, Mummery CL, Mikkers H, Freund C. Generation and genetic repair of 2 iPSC clones from a patient bearing a heterozygous c.1120del18 mutation in the ACVRL1 gene leading to Hereditary Hemorrhagic Telangiectasia (HHT) type 2. Stem Cell Res. 2020;46:101786.
Meraviglia V, Arendzen CH, Freund C, Atsma DE, Mummery CL, Bellin M. Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 gene. Stem Cell Res. 2020;45:101764.
Giacomelli E, Meraviglia V, Campostrini G, Cochrane A, Cao X, van Helden RWJ, Garcia AKrotenberg, Mircea M, Kostidis S, Davis RP, et al. Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease. Cell Stem Cell. 2020.
Brandão KO, van den Brink L, Miller DC, Grandela C, van Meer BJ, Mol MPH, de Korte T, Tertoolen LGJ, Mummery CL, Sala L, et al. Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias. Stem Cell Reports. 2020;15(5):1127-1139.
Bouma MJ, Arendzen CH, Mummery CL, Mikkers H, Freund C. Reprogramming Urine-Derived Cells using Commercially Available Self-Replicative RNA and a Single Electroporation. Curr Protoc Stem Cell Biol. 2020;55(1):e124.
2019
Tiemeier GL, Wang G, Dumas SJ, Sol WMPJ, M Avramut C, Karakach T, Orlova VV, van den Berg CW, Mummery CL, Carmeliet P, et al. Closing the Mitochondrial Permeability Transition Pore in hiPSC-Derived Endothelial Cells Induces Glycocalyx Formation and Functional Maturation. Stem Cell Reports. 2019.
Cao X, Yakala GK, van den Hil FE, Cochrane A, Mummery CL, Orlova VV. Differentiation and Functional Comparison of Monocytes and Macrophages from hiPSCs with Peripheral Blood Derivatives. Stem Cell Reports. 2019;12(6):1282-1297.
Schwach V, Fernandes MGomes, Maas S, Gerhardt S, Tsonaka R, van der Weerd L, Passier R, Mummery CL, Birket MJ, Salvatori DCF. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction. Cardiovasc Res. 2019.
Bouma MJ, Freund C, IJzerman AP, Boomsma DI, Mummery CL, Raymond K. Lymphoblast-derived hiPS cell lines generated from four individuals of a family of genetically unrelated parents and their female monozygotic twins. Stem Cell Res. 2019;41:101654.
2018
Cochrane A, Albers HJ, Passier R, Mummery CL, van den Berg A, Orlova VV, van der Meer AD. Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology. Adv Drug Deliv Rev. 2018.
Thalgott JH, Dos-Santos-Luis D, Hosman AE, Martin S, Lamandé N, Bracquart D, Srun S, Galaris G, de Boer HC, Tual-Chalot S, et al. Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2. Circulation. 2018;138(23):2698-2712.

Pages